| Literature DB >> 17918749 |
De-Hyung Lee1, Ralf A Linker, Walter Paulus, Christiane Schneider-Gold, Andrew Chan, Ralf Gold.
Abstract
Intravenous application of immunoglobulins (IVIg) is an effective and usually well tolerated yet costly therapeutic regimen in chronic inflammatory demyelinating polyneuropathy (CIDP). We report two CIDP patients treated with subcutaneous infusion of immunoglobulins (SCIg) after IVIg therapy was shown to be effective. Application of SCIg was well tolerated, easy to manage, and led to stabilization of the disease course. SCIg may represent an effective new therapeutic option in CIDP and is associated with a cost reduction of at least 50% compared to IVIg therapy.Entities:
Mesh：
Substances：
Year: 2008 PMID： 17918749 DOI： 10.1002/mus.20909
Source DB: PubMed Journal: Muscle Nerve ISSN： 0148-639X Impact factor: 3.217